| Product Code: ETC7549736 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The India organ transplant immunosuppressant drugs market import shipment demonstrated robust growth with a significant CAGR from 2020 to 2024. However, the growth rate experienced a slight decline between 2023 and 2024. Overall, the market expanded rapidly but showed a slight slowdown in the most recent period.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Organ Transplant Immunosuppressant Drugs Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Organ Transplant Immunosuppressant Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 India Organ Transplant Immunosuppressant Drugs Market - Industry Life Cycle |
3.4 India Organ Transplant Immunosuppressant Drugs Market - Porter's Five Forces |
3.5 India Organ Transplant Immunosuppressant Drugs Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 India Organ Transplant Immunosuppressant Drugs Market Revenues & Volume Share, By Transplant Type, 2021 & 2031F |
3.7 India Organ Transplant Immunosuppressant Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 India Organ Transplant Immunosuppressant Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of organ failure and chronic diseases requiring organ transplants |
4.2.2 Technological advancements in immunosuppressant drugs leading to improved efficacy and reduced side effects |
4.2.3 Growing investments in healthcare infrastructure and organ transplant facilities in India |
4.3 Market Restraints |
4.3.1 High costs associated with immunosuppressant drugs leading to affordability issues |
4.3.2 Stringent regulatory requirements and approval processes for new drugs |
4.3.3 Limited availability of organ donors leading to a gap in demand and supply for organ transplants |
5 India Organ Transplant Immunosuppressant Drugs Market Trends |
6 India Organ Transplant Immunosuppressant Drugs Market, By Types |
6.1 India Organ Transplant Immunosuppressant Drugs Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 India Organ Transplant Immunosuppressant Drugs Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 India Organ Transplant Immunosuppressant Drugs Market Revenues & Volume, By Calcineurin Inhibitors, 2021- 2031F |
6.1.4 India Organ Transplant Immunosuppressant Drugs Market Revenues & Volume, By Antiproliferative Agents, 2021- 2031F |
6.1.5 India Organ Transplant Immunosuppressant Drugs Market Revenues & Volume, By mTOR Inhibitor, 2021- 2031F |
6.1.6 India Organ Transplant Immunosuppressant Drugs Market Revenues & Volume, By Steroids, 2021- 2031F |
6.1.7 India Organ Transplant Immunosuppressant Drugs Market Revenues & Volume, By Antibodies, 2021- 2031F |
6.2 India Organ Transplant Immunosuppressant Drugs Market, By Transplant Type |
6.2.1 Overview and Analysis |
6.2.2 India Organ Transplant Immunosuppressant Drugs Market Revenues & Volume, By Kidney, 2021- 2031F |
6.2.3 India Organ Transplant Immunosuppressant Drugs Market Revenues & Volume, By Liver, 2021- 2031F |
6.2.4 India Organ Transplant Immunosuppressant Drugs Market Revenues & Volume, By Heart, 2021- 2031F |
6.2.5 India Organ Transplant Immunosuppressant Drugs Market Revenues & Volume, By Lung, 2021- 2031F |
6.2.6 India Organ Transplant Immunosuppressant Drugs Market Revenues & Volume, By Pancreas, 2021- 2031F |
6.2.7 India Organ Transplant Immunosuppressant Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.3 India Organ Transplant Immunosuppressant Drugs Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 India Organ Transplant Immunosuppressant Drugs Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.3.3 India Organ Transplant Immunosuppressant Drugs Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.3.4 India Organ Transplant Immunosuppressant Drugs Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
7 India Organ Transplant Immunosuppressant Drugs Market Import-Export Trade Statistics |
7.1 India Organ Transplant Immunosuppressant Drugs Market Export to Major Countries |
7.2 India Organ Transplant Immunosuppressant Drugs Market Imports from Major Countries |
8 India Organ Transplant Immunosuppressant Drugs Market Key Performance Indicators |
8.1 Patient survival rates post-organ transplant |
8.2 Rate of adoption of new immunosuppressant drugs in clinical practice |
8.3 Number of organ transplant procedures performed annually in India |
9 India Organ Transplant Immunosuppressant Drugs Market - Opportunity Assessment |
9.1 India Organ Transplant Immunosuppressant Drugs Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 India Organ Transplant Immunosuppressant Drugs Market Opportunity Assessment, By Transplant Type, 2021 & 2031F |
9.3 India Organ Transplant Immunosuppressant Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 India Organ Transplant Immunosuppressant Drugs Market - Competitive Landscape |
10.1 India Organ Transplant Immunosuppressant Drugs Market Revenue Share, By Companies, 2024 |
10.2 India Organ Transplant Immunosuppressant Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here